Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)

NCT05601700 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

132

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Ovarian Epithelial
Low Grade Serous Adenocarcinoma of Ovary

Interventions

DRUG: Letrozole tablets
DRUG: carboplatin AUC 5 and paclitaxel 175 mg/m2

Sponsor

Ente Ospedaliero Ospedali Galliera

Collaborators

[object Object]
[object Object]